DarioHealth prices $23.5M registered direct offering of common stock and pre-funded warrants

DarioHealth Corp.

Gross proceeds ~$23.5M from sale of 3.45M shares (or equivalents) at $6.80/share.
Offering includes 2.44M shares and pre-funded warrants for 1.02M shares; board member purchased 14,430 shares at $6.93.
Net proceeds for working capital, investments, acquisitions, and general corporate purposes.
Closing expected July 23, 2026; A.G.P./Alliance Global Partners as sole placement agent with 6% fee.
30-day restricted period on further equity issuance (except existing ATM facility).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.